© American Diabetes Association ®, Inc., 2002
Standards of Medical Care for Patients With Diabetes MellitusOriginally approved 1988. Most recent review/revision, October 2001 Abridged from Diabetes Care 25:213229, 2002.[Full Text]Full text of this position statement is available on the ADA Web site at http://care.diabetesjournals.org/cgi/content/full/25/1/213
Diabetes is a chronic illness that requires continuing medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. Diabetes care is complex and requires that many issues, beyond glycemic control, be addressed. A large body of evidence exists that supports a range of interventions to improve diabetes outcomes. These standards of care are intended to provide clinicians, patients, researchers, payers, and other interested persons with the components of diabetes care, treatment goals, and tools to evaluate the quality of care. While individual preferences, comorbidities, and other patient factors may require modification of goals, targets that are desirable for most patients with diabetes are provided. These standards are not intended to preclude more extensive evaluation and management of the patient by other specialists as needed. For more detailed information, refer to Skyler (Ed.): Medical Management of Type 1 Diabetes and Zimmerman (Ed.): Medical Management of Type 2 Diabetes. The recommendations included are diagnostic and therapeutic actions that are known or believed to favorably affect health outcomes of patients with diabetes. A grading system (Table 1), developed by the Association and modeled after existing methods, was utilized to clarify and codify the evidence that forms the basis for the recommendations.
Classification In 1997, the American Diabetes Association issued new diagnostic and classification criteria. The classification of diabetes mellitus includes four clinical classes
Screening Detection and diagnosis of GDM Recommendations A-Level evidence Expert consensus
Glycemic control Referral for diabetes management Recommendations A-Level Evidence B-Level Evidence Expert consensus Assessment of glycemic control Self-monitoring of blood glucose Recommendations Expert consensus A1C Recommendations Expert consensus MNT Recommendations B-Level evidence Physical Activity Recommendations B-Level evidence
Cardiovascular disease: management of risk factors and screening for CAD Blood pressure control Recommendations Screening and Diagnosis Expert consenus Treatment A-Level evidence B-Level evidence C-Level evidence Expert consensus Lipid management Recommendations General recommendations A-Level evidence B-Level evidence Goals B-Level evidence C-Level evidence Screening Expert consensus Treatment A-Level evidence Aspirin therapy in diabetes Recommendations A-Level evidence B-Level evidence Smoking Cessation Recommendations A-Level evidence B-Level evidence CHD screening and treatment Recommendations Expert consensus
Nephropathy screening and treatment General recommendations A-Level evidence Screening Expert consensus Treatment A-Level evidence B-Level evidence Expert consensus Foot care Recommendations A-Level evidence B-Level evidence C-Level evidence Expert consensus Diabetic retinopathy screening and treatment General Recommendations A-Level evidence Screening B-Level evidence Treatment A-Level evidence
Preconception Care Recommendations B-Level evidence C-Level evidence Expert consensus Immunization Recommendations C-Level evidence
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||